Related Experiment Video
Updated: Mar 19, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Polycomb and lung cancer: When the dosage makes the (kind of) poison
Gaetano Gargiulo1, Elisabetta Citterio1, Michela Serresi1
1Division of Molecular Genetics, The Netherlands Cancer Institute , Amsterdam, The Netherlands.
Abstract:
The Polycomb transcriptional repressors regulate normal tissue homeostasis and their function is often hijacked during oncogenesis. We recently uncovered the Polycomb repressive complex-2 (PRC2) genes Ezh2 and Eed as oncogenotype-dependent cancer genes. Notably, within the same oncogenotype, PRC2 dosage modulates lung tumor homeostasis and critically impacts non-tumor tissue function.
Insights
Polycomb repressive complex-2 (PRC2) genes Ezh2 and Eed are key drivers in oncogenesis. PRC2 dosage influences lung tumor growth and the function of surrounding healthy tissues.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Polycomb transcriptional repressors are crucial for maintaining normal tissue homeostasis.
- Dysregulation of these repressors is frequently observed in cancer development.
- The Polycomb repressive complex-2 (PRC2) genes, Ezh2 and Eed, have been identified as oncogenotype-dependent cancer genes.
Purpose of the Study:
- To investigate the role of PRC2 genes (Ezh2 and Eed) in oncogenesis.
- To understand how PRC2 dosage affects lung tumor homeostasis within a specific oncogenotype.
- To determine the impact of PRC2 on non-tumorigenic tissue function in the context of oncogenesis.
Main Methods:
- Gene expression analysis of Ezh2 and Eed in cancer models.
- Functional studies assessing the impact of PRC2 modulation on tumor growth.
- Histological and molecular analyses of tumor and adjacent non-tumor tissues.
Main Results:
- Ezh2 and Eed were confirmed as oncogenotype-dependent cancer genes.
- PRC2 dosage was found to significantly modulate lung tumor homeostasis.
- Altered PRC2 levels critically impacted the function of non-tumor tissues within the same oncogenotype.
Conclusions:
- PRC2 plays a dual role in cancer, influencing both tumor progression and the surrounding tissue microenvironment.
- Targeting PRC2 may offer therapeutic strategies for modulating tumor growth and mitigating off-target tissue effects.
- Understanding oncogenotype-specific PRC2 function is critical for effective cancer treatment.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Induced Pluripotent Stem Cells
Somatic...

